Prevalence of single-nucleotide variants in twenty-five pharmacogenes from a Cuban sample cohort

• Published in: Frontiers in pharmacology Vol. 15
• Main Authors: Reyes-Reyes, Elizabeth, Herrera-Isidrón, José Alfredo, Cuétara-Lugo, Elizabeth, Shkedy, Zhiv, Valkenborg, Dirk, Pérez-Novo, Claudina Angela, Fernández-Peña, Gisselle, González-Pérez, Idania, Fernández-Pérez, Miguel David, Vanden-Berghe, Wim, Rodeiro-Guerra, Idania
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 27.09.2024
• Subjects: admixed population; Cuban population; genetic variants; pharmacogenetic; precision medicine; single-nucleotide variants
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2024.1467036

Introduction The Cuban population is genetically diverse, and information on the prevalence of genetic variants is still limited. As complex admixture processes have occurred, we hypothesized that the frequency of pharmacogenetic variants and drug responses may vary within the country. The aims of the study were to describe the frequency distribution of 43 single-nucleotide variants (SNVs) from 25 genes of pharmacogenetic interest within the Cuba population and in relation to other populations, while taking into consideration some descriptive variables such as place of birth and skin color. Materials and Methods SNVs were analyzed in 357 unrelated healthy Cuban volunteers. Genotype, allele frequencies, and ancestry proportions were determined, and the pairwise fixation index (F ST ) was evaluated. Results Hardy–Weinberg equilibrium (HWE) deviations in six loci (rs11572103, rs2740574, rs776746, rs3025039, rs861539, and rs1762429) were identified. Minor allele frequencies (MAFs) ranged from 0.00 to 0.15 for variants in genes encoding xenobiotic metabolizing enzymes. They also ranged from 0.01 to 0.21 for variants in DNA repair, growth factors, methyltransferase, and methyl-binding proteins, while they ranged from 0.04 to 0.27 for variants in the O-6-methylguanine-DNA methyltransferase enzyme. Moderate genetic divergence was observed upon comparison to Africans (F ST = 0.071 and SD 0.079), with 19 markers exhibiting moderate-to-large genetic differentiation. The average European, African, and Amerindian ancestry proportions were 67.8%, 27.2%, and 5.3%, respectively. Ancestry proportions differed by skin color and birthplace for both African and European components, with the exception of the European component, which showed no significant difference between individuals from Western and Eastern regions. Meanwhile, the statistical significance varied in comparisons by skin color and birthplace within the Amerindian component. Low genetic divergence was observed across geographical regions. We identified 12 variants showing moderate-to-large differentiation between White/Black individuals. Conclusion Altogether, our results may support national strategies for the introduction of pharmacogenetic tools in clinical practice, contributing to the development of precision medicine in Cuba.